Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Case Report: A Psoriatic Arthritis Patient with Dactylitis & Enthesitis

Samantha C. Shapiro, MD; Jemima Albayda, MD; & Ana-Maria Orbai, MD, MHS  |  Issue: September 2018  |  September 20, 2018

Psoriatic Arthritis Described

PsA is a complex rheumatologic disease that manifests in multiple individual patterns of musculoskeletal and skin involvement. Its hallmark features include inflammatory musculoskeletal disease in the presence of active or historical psoriasis skin inflammation, or a genetic predisposition to psoriasis through family history in a first- or second-degree relative. Psoriasis prevalence in the U.S. is 2%, and roughly one in three people with psoriasis develop PsA.1

Figure 5. Dactylitis with flexor tenosynovitis and tendon Doppler enhancement.

Figure 5. Dactylitis with flexor tenosynovitis and tendon Doppler enhancement.

A study from Toronto recently described the symptoms experienced by people with psoriasis prior to a PsA diagnosis: joint pain, fatigue and stiffness.2 Classification criteria for PsA are based on clinical evaluation and exclusion of rheumatoid arthritis (see Table 2). The presence of nail psoriasis and dactylitis increase specificity for a PsA classification.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Psoriatic Dactylitis & Enthesitis

Dactylitis and enthesitis are established, disease-specific manifestations in PsA. Each affect roughly half of the patients over their lifetime, and they are associated with increased disease burden and worse patient outcomes compared to patients who do not experience these manifestations. Patho­physiology of dactylitis and enthesitis are objects of intense study, as are their longitudinal quantification and measurement.

Dactylitis is defined as inflammation affecting all anatomical layers of a digit. Acute dactylitis is tender. Permanent damage has been demonstrated in digital joints affected by dactylitis, so it has a prognostic role as a sign of disease severity. In the CASPAR classification study, dactylitis increased the odds of PsA by 5.5–20 (historical dactylitis 5.5 and 95% CI 1.8–17; acute dactylitis 20 and 95% CI 5.9–67).

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Enthesitis is defined as inflammation localized to the insertion sites of tendons and ligaments at the bony surface. The human body has more than 100 entheses; examples include the Achilles tendon insertion at the calcaneus, the annulus fibrosus insertions at the vertebral bodies, the sacroiliac joints and the flexor tendon insertions of the phalanges.

Enthesitis is a prominent feature of PsA and is included as part of the stem for the 2006 CASPAR criteria.3 Enthesitis leads to greater overall disease burden with poorer functional status, greater patient-reported pain and fatigue, and impairment of work and activities.4

Epidemiology

A diagnosis of dactylitis is based on clinical appearance and is best described as a sausage digit (see Figures 1 and 2). Dactylitis occurs in 40% of adult patients with established PsA.5 Examination of the feet is critical in diagnosing dactylitis because it can occur equally in fingers and toes. In the U.S. multicenter CORRONA PsA registry, prevalence of dactylitis in a cross-sectional PsA sample measured 15%.4 Dactylitis can occur in patients who are already taking PsA treatments, and when that happens, it is a sign of active or poorly controlled psoriatic disease.

Page: 1 2 3 4 5 6 7 8 9 | Single Page
Share: 

Filed under:ConditionsOther Rheumatic ConditionsPsoriatic Arthritis Tagged with:DactylitisEnthesitisPsAPsoriatic Arthritis

Related Articles

    Psoriatic Arthritis: Advances in Therapeutics, Imaging & More Presented at ACR Convergence 2022

    December 1, 2022

    PHILADELPHIA—Selecting my top 10 picks for abstracts in psoriatic arthritis (PsA) at the ACR Convergence 2022 meeting was not easy because there was a great deal to review and learn from the 139 abstracts submitted to the meeting. I focused first and foremost on advances in therapeutics that encompassed both new and approved therapeutics, novel…

    The Heterogeneity of Psoriatic Arthritis

    November 21, 2023

    SAN DIEGO—Differences between psoriatic arthritis and rheumatoid arthritis highlight the need for the development of imaging modalities, laboratory tests and other biomarkers that are explored and validated specifically for PsA to advance the goal of personalized or precision medicine. In this article, expert David S. Pisetsky, MD, PhD, explores the top research in psoriatic arthritis presented at ACR Convergence 2023.

    Looking to Psoriatic Arthritis History to Disrupt Current Thinking

    May 4, 2022

    As the cloud moved away from the tent, Miriam’s skin suddenly became diseased, as white as snow. When Aaron turned toward her, he saw that she was diseased. —Numbers 12:10 ad goes here:advert-1ADVERTISEMENTSCROLL TO CONTINUEFor 29 years he [Fray Pedro de Urraca] was afflicted by … pain, suffering it at once in all the joints…

    Psoriatic Arthritis: From Leeds to the Limelight

    August 1, 2009

    Advances in understanding of the disease begin in the 1960s

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences